Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics

This viewpoint uses the absence of known effective treatment for Ebola virus disease to emphasise costs of off-label and compassionate drug use during an infectious disease outbreak.

Journal of the American Medical Association